Selecting the Right Disinfectant When It’s Needed Most

GeoVax CEO David Dodd discusses how vaccine storage requirements, supplier diversification, and regional manufacturing shape outbreak preparedness, with considerations for infection preventionists and health systems preparing to receive and administer doses.

Part 4 of 4: Why better planning for surgical growth, operational performance, and patient safety requires sterile processing expertise early in the decision-making process.

An emerging cause of sexually transmitted ringworm, TMVII can resemble other skin conditions and require prolonged treatment. Learn what clinicians and infection preventionists should know about recognition, specialized testing, and patient counseling.

3 of 4: How technology, artificial intelligence, automation, and data are reshaping sterile processing leadership

Part 2 of 4: Recruitment may bring people into sterile processing. Development is what determines whether they stay.

At IDWeek 2026, Rachel Sidebottom discusses research exploring phage-antibiotic combinations, the potential for predictive modeling, and an investigation identifying an ST5 strain of nontoxigenic Corynebacterium diphtheriae circulating in Albuquerque.

Finding infections earlier is only part of the work. At IDWeek 2026, David Weber, MD, MPH, explored how broader surveillance and emerging technologies could help infection preventionists spend more time supporting safer care.

Two experts give an update ahead of the first season with a new mRNA vaccine against flu.